|
HS Code |
787827 |
| Product Name | Junci Medulla Veterinary Grade API |
| Appearance | Light yellow to brownish fibrous substance |
| Purity | ≥98% |
| Usage | Active Pharmaceutical Ingredient (API) for veterinary medicines |
| Dosage Forms | Tablets, Injections, Capsules, Powders, Granules, Premix, Solutions |
| Solubility | Slightly soluble in water, soluble in alcohol |
| Animal Target | Livestock and poultry |
| Storage Conditions | Store in a cool, dry place away from light |
| Shelf Life | 24 months |
| Main Component | Junci Medulla (pith of Juncus effusus) |
| Package Size | 1 kg, 5 kg, 25 kg drum/bag |
| Quality Standard | Veterinary GMP |
| Application | Veterinary anti-inflammatory and diuretic uses |
| Origin | Plant-based raw material |
| Country Of Manufacture | China |
As an accredited Junci Medulla Veterinary Grade API for Tablets / Injections / Capsules / Powders / Granules / Premix / Solutions factory, we enforce strict quality protocols—every batch undergoes rigorous testing to ensure consistent efficacy and safety standards.
| Packing | Sealed 1 kg aluminum foil bag, labeled "Junci Medulla Veterinary Grade API," suitable for tablets, injections, capsules, powders, and solutions. |
| Shipping | The Junci Medulla Veterinary Grade API is securely packaged in tamper-proof, moisture-resistant containers. Shipping is conducted via certified carriers under controlled temperature conditions to ensure product stability. Suitable for various formulations—tablets, injections, capsules, powders, granules, premix, and solutions—each batch is traceable and accompanied by relevant documentation and certificates. |
| Storage | Store Junci Medulla Veterinary Grade API in a cool, dry, and well-ventilated area, away from direct sunlight, moisture, and incompatible substances. Keep the container tightly closed and clearly labeled. Store at room temperature (15–25°C), and ensure the chemical is protected from heat and ignition sources. Follow all regulatory guidelines for the storage of pharmaceutical-grade raw materials. |
Applications of Junci Medulla Veterinary Grade API for Tablets / Injections / Capsules / Powders / Granules / Premix / Solutions in Industrial ManufacturingAs a dedicated manufacturer of veterinary grade Junci Medulla API, we focus on supporting downstream pharmaceutical and feed enterprises with reliable, process-ready material for integration into multiple finished dosage forms. Our API finds established use in regulated veterinary health product sectors globally, where compliance, traceability, and rational formulating take precedence throughout all stages of industrial value chains. 1. Veterinary Tablet Production for Companion and Livestock AnimalsTablet manufacturing facilities leverage our Junci Medulla API thanks to its consistent particle size and defined assay, ensuring reproducible performance within batch-controlled systems. Our product integrates directly during the granulation phase, interacting with excipients and active bases predetermined by veterinary manufacturers to match species-specific therapeutic needs. Processing personnel dose to specification per animal and region, aligning with local veterinary monographs and GMP rules. The finished tablets typically target standardized treatment protocols in pigs, poultry, cattle, and companion animal sectors, and formulation engineers adjust use rate in line with regulatory and animal weight requirements. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
2. Sterile Injectable Veterinary Solution ManufacturingInjection solution factories require consistently pure API suitable for aseptic filtration, with particle and solubility profiles documented batch by batch. Downstream, the API enters tank dissolution in compounding suites under controlled pH and temperature, meeting critical quality attributes set by veterinary injection standards. Concentration for sterile injection varies by target animal and prescribed indication, with stability trials guiding optimal loading in the final solution to benefit from Junci Medulla’s validated actives and safe excipient compatibility. Stringent documentation tracks batch genealogy from raw API through to the final vial or ampoule. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
3. Veterinary Oral Powders and Soluble Granules for Feed MixingOral powder and granule lines utilize our API for ad-libitum or measured dosing via integration into soluble or dispersible preparations. Downstream manufacturers rely on precise API blending with carriers and functional excipients to assure even distribution and minimal segregation. Feed premix plants adjust dosing rates according to nutritional and disease prevention protocols in poultry houses, swine cycles, or cattle finishing operations, ensuring contents dissolve or suspend readily depending on farming practice. All label claims must remain within compliance for feed additives and finished feed medicaments. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
4. Veterinary Premix Applications in Intensive Animal FarmingFeed manufacturers processing premix formulations employ our API to support health management routines in intensive animal rearing systems, mixing it with vitamin-mineral complements and nutritional carriers. This application centers on the precision introduction of the API via batch blending systems with automated metering to ensure dosage accuracy for subsequent custom feed production. Since each premix batch enters a critical traceability net covering farms and veterinary oversight, plants operate according to special GMP for feed and veterinary drug integration. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
|
Competitive Junci Medulla Veterinary Grade API for Tablets / Injections / Capsules / Powders / Granules / Premix / Solutions prices that fit your budget—flexible terms and customized quotes for every order.
For samples, pricing, or more information, please contact us at +8615365186327 or mail to admin@ascent-chem.com.
We will respond to you as soon as possible.
Tel: +8615365186327
Email: admin@ascent-chem.com
Flexible payment, competitive price, premium service - Inquire now!
Every kilogram of Junci Medulla Veterinary Grade Active Pharmaceutical Ingredient (API) in our facility emerges from a line where precision guides every decision. We select raw Junci Medulla herb after a long vetting process that checks its identity and closely monitors the growing region for standards of soil, water, and harvest maturity. Only lots that show a full phytochemical profile within the veterinary range ever move on to processing. The raw fibers and plant tissue are pulped, fragmented, and subjected to temperature and pressure patterns based on years of laboratory validation. Our process transforms Junci Medulla into a uniform, stable powder or extract designed to anchor a wide variety of veterinary dosage forms.
Through direct solvent extraction, microfiltration, and recrystallization steps, we minimize contaminants at each stage. Cleanroom environments take over once material enters the finishing section. In-house labs check for bacterial load, pesticide residue, and heavy metals, as regulated by both local agricultural boards and international veterinary pharmacopeia. Each lot receives a unique code and batch record, letting us trace every bag or drum back to its farm and supplier batch. We use high-performance liquid chromatography (HPLC) and capillary electrophoresis to confirm the active compound’s spectrum in each gram. This labor ensures that when a customer receives Junci Medulla API, they receive a product with known content, free from farm-to-finish surprises.
Our clients range from injectable veterinary drug makers to powder feed supplement facilities. We have seen how the choice of base material changes the flow of an entire production line. For tablets, the fine granularity and moisture content of the API let it compress smoothly and bind evenly with filler materials. The injection-grade batches go through sterile filtration twice, allowing suspension in both oil-based and aqueous carriers. Capsule manufacturers benefit from our increased bulk density controls, which solve the “settle fill” problem by supporting higher fill weights with tighter volume tolerances. Powder blends use a version with specific moisture and particle size to stop caking during transport. Granule and premix customers depend on our work in blending rates, which sets up consistent batch-to-batch dispersal in animal diets. Water- or oil-based solutions employ our absolute-purity extract to give a clear, stable dose in every final bottle.
Unlike commodity-grade Junci Medulla products which flood the market with variable alkaloid or flavonoid content, our veterinary grade maintains a verifiable marker compound percentage. Each shipment arrives with a CoA representing testing on final form, not just on source raw material. We do not batch-mix harvests from different origins or multiple collection years; all ours comes from single-source supply, harvested within a specific time window to limit alkaloid instability. We have watched animal health outcomes deteriorate after clinics switched to variable-supply APIs. Our consistency means a day-to-day dose really matches what veterinarians prescribe—this matters when treating herd-wide conditions, chronic disorders, or vulnerable populations.
Early on, filtration bottlenecks and batch-to-batch differences used to challenge our throughput. One harvest, heavy monsoon rains increased plant moisture, which complicated powder consistency. We responded by installing inline near-infrared (NIR) moisture analyzers. Today, process operators make live adjustments to drying times so finished API always sits in our validated 5-6% moisture band. In another incident, a shipment flagged for unusually high ash content led us to upgrade our pollution monitoring on contracted farms. Our team retrieves root and stem samples monthly from multiple field sections, reducing the chance of contaminated or adulterated harvests making it into production.
We invest in experienced technicians and continuous training, updating SOPs after every season if root causes warrant it. We have never lost sight of how animal health depends on the diligence of every processor, not just on good paperwork or regulatory checkboxes. Animal clinics and pharma partners have, more than once, noted that treatments compounded with our API lead to fewer complaints about adverse reactions or unexplained potency drift.
The people who call our technical support desk range from regulatory affairs managers at large international pharma companies to rural veterinarians mixing on-farm doses. We regularly field questions about batch trackability, residue levels, time-of-harvest, and blending rates with specific excipients or stabilizers. One recurring concern comes from clinics seeking to avoid subtherapeutic dosing due to low-variance product. To answer, we supply detailed HPLC fingerprints and multi-day stability profiles, sampled at both 3°C and 25°C. We also share our rejection logs showing which lots failed—transparency not always found on the open market.
Some premix clients ask about palatability in compound veterinary feeds. Through cooperative feeding trials, we tracked acceptance rates on modified diets, correlating them to our API’s particle size and bitterness, prompting us to offer tailored mesh sizes for water-soluble and feed-mix applications. Granule and powder clients sometimes worry about static charge during blending—our facilities run calendared roll processing and, where needed, antistatic additives that pass food safety muster.
Our production lines operate under current GMP, with all critical process parameters logged for at least five years. Auditors from both domestic agencies and international partners routinely inspect our records and site practices. Certificates on heavy metals, pesticides, solvent residues, and microbial limits come from third-party labs and are available with every drum.
Over the years, we have adapted our documentation and batch traceability to support veterinary dossier submissions in several jurisdictions known for strict regulatory standards. This readiness helps clients, especially multinational firms, who must demonstrate consistent sourcing, validated manufacture, and up-to-date certificate logs. Our involvement does not end at shipment: if a regulatory query arises post-market about a batch, our records can show full traceability to date of harvest and all analysis performed.
Junci Medulla’s role in animal medicine has grown as more practitioners look for alternatives to heavily regulated or residual-prone drugs. Our work extends beyond bulk manufacturing to advisory collaboration with veterinary researchers, nutritionists, and clinical pharmacists. We provide small-batch pilot lots for veterinarians designing new stabilized formulations or combination therapy trials. The detailed feedback from these partners, both on herd outcomes and on laboratory stability profiles, feeds directly back into our process upgrades.
Several clients working with poultry and aquaculture have documented reduced residue carryover and minimal withdrawal time after treating with our API-based solutions. Ruminant clinics relying on tablet and powder applications highlight fewer reports of intolerance, attributed to our control over both physical and chemical profile.
What sets our operation apart is a manufacturing culture open to critiques and improvements. A few years ago, research flagged trace contaminants from legacy drying equipment. We replaced it with a new low-heat, vacuum-assisted system that both retains the original marker compounds and prevents thermal degradation that could hamper bioavailability. When changes in the field lead to higher bioactive variation in plants, botanists, agricultural contractors, and process technologists work together to recalibrate the standard, ensuring every incoming load is held to the same known effect standard, not simply the origin label or supplier assumptions.
Regular panels with animal health experts, university labs, and feed manufacturers allow us to anticipate industry direction. Whether it’s anticipating future EU restrictions on specific process auxiliaries or pre-emptively addressing plasticizer carryover in packaging, we adapt before a regulatory letter arrives. New rapid microbiology testing now catches low-level contamination within hours instead of days, giving us time to react without late-stage batch recalls.
Feedlot managers, aquaculture producers, and veterinary pharmacists all demand certainty in supply. By controlling the entire “farm to factory” chain ourselves, we build in enough redundancy to weather seasonal shortfalls or logistics bottlenecks. Several global clients shifted to our facility because previous suppliers ran short without notice or shifted quality with every new shipment. Through buffer stock and flexible line scheduling, we maintain regular API output even when weather or regulatory shocks hit source regions.
This reliability, paired with product format customization—be it low-moisture powder for effervescent premix or extra-fine crystal for rapid-dissolving injections—roots our partnership with end users in their real-world process needs, not just paperwork satisfaction.
Ethical stewardship of plant resources and clear, measured production standards shape our company’s approach. Junci Medulla’s growing popularity has sometimes led to overharvesting or rushed processing outside regulated supply chains. Our contracts with growers specify sustainable cutting, allowing light regrowth and reducing impact on local plant populations. Frequent audits and independent botanical authentication guard against substitutions, mishandling, or fungal contamination.
More than once, industry associations reached out to us for guidance on scaling up veterinary use without depleting wild sources. Years of firsthand data on sustainable yield, soil restoration, and running tight grower partnerships taught us that steady, fair returns for producers lead to reliable quality upstream. The cycle benefits every link—from farm, to processor, to vet, to animal—when managed transparently.
Global animal health faces pressure to improve outcomes on farms, aquaculture sites, and clinics, often under regulatory scrutiny and increasing consumer awareness. Junci Medulla Veterinary Grade API has grown into a trusted element in pharmaceutical-grade animal treatments, precisely because direct manufacturing experience teaches that predictable sourcing, careful process design, and supply chain clarity matter more than any marketing claim.
New clients join familiar partners in seeking not just product—it’s the shared expertise and openness to troubleshooting that bring them to our doors. Veterinary medicine evolves as awareness grows about material origin and manufacturing transparency. We meet these demands with accessible technical reports, authentic dialogue, and solutions based on lessons learned from every past challenge.
Animal health will only get more demanding as therapies grow more complex, regulations get tougher, and veterinarians and animal managers look for higher confidence in every treatment delivered. We keep advancing, learning from every batch and every call, investing in new analytic tools, and prioritizing field feedback. The trust we earn through consistency, honesty, and practical technical support sustains our product and our partnerships.
For every kilogram of Junci Medulla Veterinary API that leaves our warehouse, a careful chain of hands, eyes, and records stands behind it. Every client who chooses our product joins that chain—and we welcome every question, improvement, and challenge to keep setting the standard for veterinary APIs.
